| Breast Cancer |
1 |
0.9 |
| Breast |
0 |
0.59 |
| Cancer Risk |
0 |
0.51 |
| Depression |
0 |
0.46 |
| Ovarian Cancer |
0 |
0.39 |
| Hysterectomy |
0 |
0.32 |
| Cardiovascular Risk Management |
0 |
0.26 |
| Estrogen |
0 |
0.21 |
| Coronary Artery Disease (CAD) |
0 |
0.17 |
| Selective Estrogen Receptor Modulators (SERMs) |
0 |
0.14 |
| Heart |
0 |
0.13 |
| Lipids Management |
0 |
0.13 |
| Hormonal Therapy |
0 |
0.11 |
| Antidepressant drug |
0 |
0.1 |
| Cardiovascular disease |
0 |
0.1 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Major Depression |
0 |
0.1 |
| Preoperative |
0 |
0.1 |
| Selective Serotonin-Reuptake Inhibitors (SSRI) |
0 |
0.1 |
| Transdermal |
0 |
0.1 |
| UK Site Content |
0 |
0.1 |
| Clinical Research |
0 |
0.08 |
| Oophorectomy |
0 |
0.08 |
| Fellowship |
0 |
0.06 |
| Endometriosis |
0 |
0.05 |
| Adhesion |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Cerebrovascular Accident |
0 |
0.04 |
| Epidemiology |
0 |
0.04 |
| LDL Cholesterol |
0 |
0.04 |
| Lipoproteins |
0 |
0.04 |
| Mood Disorders |
0 |
0.04 |
| Progestin |
0 |
0.04 |
| Smoking |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Vagina |
0 |
0.04 |
| Weight Gain |
0 |
0.04 |
| Bone Density |
0 |
0.03 |
| Contraception |
0 |
0.03 |
| Sleep Disorders |
0 |
0.03 |
| Tobacco Cessation |
0 |
0.03 |
| Weight Management |
0 |
0.03 |
| Abdomen |
0 |
0.02 |
| Anxiety |
0 |
0.02 |
| Anxiety Disorder |
0 |
0.02 |
| Aromatase Inhibitors |
0 |
0.02 |
| Atherosclerosis |
0 |
0.02 |
| Body Mass Index |
0 |
0.02 |
| Bone |
0 |
0.02 |
| California |
0 |
0.02 |
| Canada |
0 |
0.02 |
| Chemoprophylaxis |
0 |
0.02 |
| Diet |
0 |
0.02 |
| Exercise |
0 |
0.02 |
| Hormone Replacement Therapy |
0 |
0.02 |
| Mammogram |
0 |
0.02 |
| Massachusetts |
0 |
0.02 |
| Match |
0 |
0.02 |
| Meta-Analysis |
0 |
0.02 |
| Metabolic Syndrome |
0 |
0.02 |
| Metabolism |
0 |
0.02 |
| Muscle |
0 |
0.02 |
| Physiology |
0 |
0.02 |
| Premenstrual Dysphoric Disorder |
0 |
0.02 |
| Preventive Medicine |
0 |
0.02 |
| Primary Care |
0 |
0.02 |
| Prophylaxis |
0 |
0.02 |
| Sexual Dysfunction |
0 |
0.02 |
| Sleep |
0 |
0.02 |